Beyond genetics and lifestyle, the gut microbiome is now emerging as an important factor in cancer progression and treatment response. This raises an important question: could understanding and targeting this ecosystem transform the way we treat cancer?
From diet to microbiome therapies: Key insights from the GMFH Summit 2026
19 May 2026by Manon Oliero, Giovana Martucelli, Andreu Prados
The 14th edition of the Gut Microbiota for Health World Summit brought together leading researchers from around the world to present the latest advances in the field. The meeting reinforced clinical practices that have become increasingly established in recent years and also presented unpublished results on new microbiome-targeted therapies, in line with the summit’s central theme: “Diet and other ways to manipulate the gut microbiome in clinical practice.”
Cancer and microbiome: newsflash on epidemiology, fungi in etiology, and microbiome-derived markers for diagnosis
22 Mar 2023by Konstantina Zafeiropoulou
Following the GMFH 2022 Year at a Glance report, it is time for a flashback in the latest research on cancer microbiome. This post ranges between the epidemiology, etiology and diagnosis of cancer, looking at the role of fungal and bacterial gut microbiome in all three health care branches.
Antimicrobial additive triclosan exacerbates inflammation and colitis-associated colon cancer in mice
25 Jun 2018by Andreu Prados
A new study has found that exposure to triclosan increases colonic inflammation and colitis-associated colon tumorigenesis in mice.
A new study establishes relationships between miRNA expression and gut microbiome composition in cancer patients
21 Jun 2018by Andreu Prados
This is the first study that characterizes relationships between gut microbial communities and miRNA expression in human CRC tissues.
A review discusses new evidence for the role of gut microbiota in figuring out whether a patient will respond to cancer therapies
15 Feb 2018by Andreu Prados
A review by Dr. Christian Jobin discusses how cancer immunotherapies could be used with more precision when considering gut microbiota-mediated interactions with the immune system.
A diet rich in prebiotics and probiotics may have a significant effect on preventing cancer: Interview with Núria Malats
20 Sep 2017by Cristina Sáez
During the BDebate conference, Núria Malats, a researcher at the Spanish National Cancer Research Centre (CNIO), answered questions about gut microbiota’s influence on drug efficacy.
In the past decades, some studies have shed light on the importance of diet in reducing the risk of cancer.
Interview with Francisco Guarner and Gail Hecht: “How gut microbiota discoveries can impact our health”
16 Nov 2016by GMFH Editing Team
During the 5th Gut Microbiota for Health World Summit 2016, held in Miami, we had the opportunity to talk to Francisco Guarner.
